ÂÜÀòÂÒÂ×

Kimberly Manhard is a seasoned executive in the biopharmaceutical industry, currently serving as Chief Development Officer and Executive VP at Connect Biopharma since September 2024. With a strong background in drug development, Kimberly has held leadership positions at several organizations, including Executive VP at Heron Therapeutics, Inc., and Senior VP at AstraZeneca. Manhard is also an active board member for multiple companies, including Shoreline Biosciences, Inc., Inhibrx, Inc., and Toragen, Inc., as well as a member of the Board of Trustees for the Fleet Science Center. Additionally, Manhard has experience as a Drug Development Consultant and previously served as President of Manhard Pharma Consulting. An alumnus of the University of Florida, Manhard holds a Bachelor's Degree with a double major in Zoology and French.